Fermer le menu


Member of Lyonbiopole


CellMade is a biopharmaceutical company focused on the development and commercialization of early diagnostic and prognostic tests and novel therapeutics to prevent development of the Metabolic Syndrome and related co-morbidities. CellMade was established in France, in September 2007. It developed its proprietary technology platform CellInsight linking tissue acquisition activities, cell production and characterization, development of ex vivo 3D models with an innovative analytical approach being cytometry couple to (off-line) mass spectrometry). CellMade's lead product, co-developed along with a diagnostic and prognostic biomarker signature, is evaluated for potential indications in the treatment of Non-Alcoholic Fatty Liver Disease (NAFLD, NASH).


Strategic application domain: Human Medicine

Application market: Cardiology, Metabolic Disorders - Endocrinology

Type of activity: Diagnostics, Therapeutics, Pharma or Biotech

Technologies: Cell Therapy - Stem cells - Cell Biology - Biobanking, Screening methods or services

Created on sept. 4th, 2007 - 2 employees






Vous devez être connecté et membre de Lyonbiopôle pour voir les contacts.